WallStreetZenWallStreetZen

NASDAQ: BCYC
Bicycle Therapeutics PLC Stock Ownership - Who owns Bicycle Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Bicycle Therapeutics PLC insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Kevin LeeCHIEF EXECUTIVE OFFICER2026-04-061,716$5.05
$8.67kSell
Michael SkynnerCHIEF SCIENTIFIC OFFICER2026-04-06525$5.05
$2.65kSell
Travis Alvin ThompsonChief Financial Officer2026-04-06102$5.05
$515.10Sell
Michael Charles Ferguson HannayCHIEF PROD SUPPLY CHAIN OFF2026-04-06251$5.05
$1.27kSell
Jennifer Scott PerryChief Operating Officer2026-04-06333$5.04
$1.68kSell
Jennifer Scott PerryChief Operating Officer2026-04-0637$5.05
$186.85Sell
Kevin LeeCHIEF EXECUTIVE OFFICER2026-04-025,967$4.91
$29.30kSell
Travis Alvin ThompsonChief Financial Officer2026-04-02799$4.91
$3.92kSell
Michael Charles Ferguson HannayCHIEF PROD SUPPLY CHAIN OFF2026-04-021,521$4.91
$7.47kSell
Michael SkynnerCHIEF SCIENTIFIC OFFICER2026-04-021,879$4.91
$9.23kSell

1 of 5

BCYC insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when BCYC insiders and whales buy or sell their stock.

BCYC Shareholders

What type of owners hold Bicycle Therapeutics PLC stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Baker Bros Advisors LP15.59%10,885,357$47.46MInstitution
Baker Bros Advisors LP14.35%10,018,674$43.68MInsider
Fcpm III Services Bv4.97%3,468,430$15.12MInstitution
Armistice Capital LLC4.87%3,398,000$14.82MInstitution
Long Focus Capital Management LLC4.74%3,310,687$14.43MInstitution
Carolyn Ng2.86%1,998,580$8.71MInsider
Acadian Asset Management LLC2.82%1,968,025$8.58MInstitution
Tybourne Capital Management Hk Ltd2.80%1,957,961$8.54MInsider
Deborah Harland2.74%1,915,275$8.35MInsider
Svlsf V LLC2.74%1,915,274$8.35MInsider

1 of 3

BCYC vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
BCYC53.41%43.65%Net SellingNet Selling
TENX72.65%27.35%Net Buying
NAUT36.88%63.12%Net BuyingNet Buying
IVVD71.04%28.96%Net Selling
DMAC21.71%69.04%Net Buying
View Top Biotech Stocks

Bicycle Therapeutics Stock Ownership FAQ

Who owns Bicycle Therapeutics?

Bicycle Therapeutics (NASDAQ: BCYC) is owned by 53.41% institutional shareholders, 43.65% Bicycle Therapeutics insiders, and 2.95% retail investors. Baker Bros Advisors LP is the largest individual Bicycle Therapeutics shareholder, owning 10.02M shares representing 14.35% of the company. Baker Bros Advisors LP's Bicycle Therapeutics shares are currently valued at $43.58M.

If you're new to stock investing, here's how to buy Bicycle Therapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.